Our Library
| Screening | |
| US Food and Drug Administration Summary Basis for Approval for the NGI UltraQual HCV RT-PCR Assay |  |
| US Food and Drug Administration Summary Basis for Approval for the NGI UltraQual HIV-1 RT-PCR Assay | |
| Large Scale PCR Screening of Pooled Plasma Samples for HIV-1 and HCV | |
| HCV | |
| Ultracentrifugation and Concentration of a Large Volume of Serum for HCV RNA During Treatment May Predict Sustained and Relapse Response in Chronic HCV Infection |  |
| An Analysis of Acute Changes in Interleukin-6 Levels After Treatment of Hepatitis with Consensus Interferon | |
| The Clinical Utility of Using Catrimox-14-treated Whole Blood in Detecting Hepatitis C Virus RNA | |
| Induction of IL-1Ra in Resistant and Responsive Hepatitis C Patients Following Treatment with IFN-con1 | |
| HIV | |
| Acute HIV Infection, An Opportunity To Enhance Primary Prevention | |
| Oncology | |
| Changes in the Presence of Multiple Markers of Circulating Melanoma Cells Correlate with Clinical Outcome in Patients with Melanoma | |
| Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Analysis of Nonsentinel Nodes Following Completion Lymphadenectomy for Melanoma | |
